Can Binge-Watchers Keep Up With The Market?
Photo Credit: Global Panorama Netflix has some interesting stats to pay attention to this quarter. There is a 13% difference in Estimize and Wall Street’s EPS estimates for FQ2’17, $0.18 and $0.16 respectively. However, both platforms pretty much agree on NFLX’s revenue for this quarter; Estimize predicting $2,764M and The Street estimating $2,759M in revenue. Likewise, NFLX […]
Barron’s Curses Bitcoin
The cover curse continues to have great strength… Of course, Barron’s isn’t alone in this wicked potency…
Billion Dollar Unicorns: Garena Files Privately In New Avatar
Singapore-based Garena became the most valuable Billion Dollar Unicorn from South East Asia riding on the popularity of its games. It has now expanded into e-wallets and e-commerce in the South East Asian region and has filed privately for an IPO after rebranding itself as Sea. Sea’s Journey When Forrest Li heard Steve Job’s famous “Stay hungry, stay […]
4 Sell-Ranked Drug Stocks To Avoid Ahead Of Q2 Earnings
Earnings season for the biotech and pharma sector kicks off this week with industry bellwether Johnson & Johnson (JNJ – Free Report) reporting second quarter results tomorrow before the market opens. Swiss pharma giant, Novartis (NVS – Free Report) , which was in the news recently related to a favorable FDA advisory panel recommendation for its CAR-T cell therapy, […]
AUD/USD Creates Big Double-Top At 0.7840
The Australian dollar has a good memory for old lines. The cycle high of 0.7840 was recorded back in April 2016. 15 months later, AUD/USD approaches this line very slowly but once it gets too close, it suddenly drops. At least for now, Aussie/USD is rejected from this resistance line and forms a double-top. Will […]
Gold, Silver And Miners Are Sizzling Hot
Gold and Silver prices have reached important long-term buying interest areas last week and we have the first reversal signs. I remain longer-term bullish and you were notified promptly by the wedge pattern breakout and the warning signs we were given before the upside reversal. My minimum bounce target is at $1,260 but overall I believe […]
TherapeuticsMD Drops As TX-004HR Update Seen Not Reading ‘Well At All’
Shares of TherapeuticsMD (TXMD), a women’s healthcare company, plunged in pre-market trading after the company provided a regulatory update on the status of its New Drug Application for TX-004HR. REGULATORY UPDATE: In a statement, TherapeuticsMD provided an update on the status of its NDA for TX-004HR, its investigational applicator-free estradiol vaginal softgel capsule for the […]
New All Time Highs For The Stock Market – What Matters Now?
All time highs without a worry in this world. It really is impressive how the market will rebound every time from even the smallest of sell-offs to hit new all-time highs, time and time again. There is a lot of risk out there – tons of it. Despite all the horrible headlines that could readily […]
Why No One Hears The Alarm Bells
Alarm Bells are ringing everywhere in the hedge fund industry. The problem is that no one seems to hear them. Liquidity, Liquidity, liquidity. That’s all you need to know about this market. Chaos in Washington doesn’t count. The economy doesn’t count. Geopolitics don’t count. Even the weather doesn’t count, unless you’re a long suffering, but […]
US Tax Efforts Still Moving Forward
The health care reform efforts have disappointed. The House version has been all but forgotten about as the focus has shifted to the Senate. The challenge in the House has been repeated in the Senate, namely that the differences between different parts of the coalition embodied in the Republican Party are preventing the emergence of a working majority. The […]
